ASTH

ASTH AI Signal Analysis

Multi-agent conviction signals powered by SEC filings, insider trades, institutional holdings, and earnings data

1signals

avg conviction-8

0/0

Mar 28, 2026

conviction

Neutral(low)

ASTH shows a sharp operating cash flow improvement of +119.5% YoY and a single-quarter EPS beat of 11.0%, but has beaten estimates in only 1 of 4 recent quarters, reflecting inconsistent execution that undermines confidence in sustained outperformance. Options positioning is structurally bullish with a put/call volume ratio of 0.05 and open interest skewed heavily toward calls, yet the net 48-hour flow turned modestly bearish at -$41K driven by $85K in bearish sweeps, creating a mixed near-term signal. Filing similarity scores of 93-99% across all sections suggest management is not communicating meaningful strategic evolution, which is a concern for a company in a dynamic healthcare services environment. The weight of evidence supports a cautious, near-term-only tactical stance with no durable multi-month conviction.

+18

-8

Agent Breakdown

Fundamentals AgentBearish

-12

Despite a strong operating cash flow surge (+119.5% YoY) and a one-quarter EPS beat of 11.0%, ASTH has beaten estimates in only 1 of 4 recent quarters, indicating inconsistent execution. Filing similarity scores of 93-99% across all sections signal minimal strategic evolution and raise concerns about management's forward visibility and adaptability.

Sources

ForensicForensic score: 100/100 (0 flags)
Filing ChangeFinancial Notes — minor changes
Filing ChangeMda — minor changes
Filing ChangeRisk Factors — minor changes
Filing ChangeBusiness — minor changes
EarningsEPS beat: $0.12 vs $0.11 est (+11.0%)
Analyst RatingAnalyst consensus: 7 strong buy, 7 buy, 3 hold, 0 sell, 0 strong sell

Options AgentBullish

+42

The options market shows a strongly skewed call-side structure with a put/call volume ratio of 0.05 (5,391 calls vs. 265 puts) and OI heavily weighted toward calls (6,684 vs. 952), while 30-day OI has grown +16K over 9 days with 4 bullish accumulation days and zero bearish — suggesting directional call positioning. However, the net 48h flow is modestly bearish at -$41K driven by $85K in bearish sweeps against negligible bullish dollar flow, and the ATM put mispricing of -100% signals potential data anomaly or illiquidity on the put side that warrants caution.

Sources

IV DataIV metrics: 55.6% percentile, IV/HV ratio 1.06

Unlock agent-level analysis

See exactly what each AI agent found — forensic accounting flags, insider clusters, institutional shifts, and more.

Get started View pricing

Trade Plan

Live Return

$24.19-0.3%

Entry: $24.27 · 0d elapsed / 30d horizon

Tracking

Entry Zone

In entry zone

$23.50

$24.75

Valid until Apr 10, 2026

Price Targets (30-day)

Bull

$28.50+17.8%

Call-side OI surge materializes into a momentum squeeze toward prior resistance near $28-29 if earnings execution improves

Base

$26.50+9.5%

Modest mean reversion toward fair value supported by cash flow improvement but capped by inconsistent earnings history

Bear

$21.50-11.1%

Thesis invalidation on weak next earnings print or broader sector de-rating drives retest of $21-22 support

Stop Loss

$21.75

-10.1%

Position Size

1-2%

of portfolio

Risk/Reward

1.8x

base target

Unlock the trade plan

Get entry zones, price targets, stop loss levels, and position sizing for every signal.

Get started View pricing

Get the full picture on ASTH

Our AI analyst team runs 5 specialized agents on every stock. Unlock detailed breakdowns, trade plans, and real-time alerts.

Start for $9/mo View pricing

Not financial advice. For informational purposes only. Past performance does not guarantee future results.